𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transcriptional enhancers play a major role in gene expression

✍ Scribed by Bruce L. Rogers; Grady F. Saunders


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
515 KB
Volume
4
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Transcriptional regulation of urokinase
✍ Rosie H. Xing; Shafaat A. Rabbani πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 156 KB πŸ‘ 2 views

Carcinoma of the breast is a leading hormone-dependent malignancy, resulting in a high rate of morbidity and mortality. During the complex multi-step process of tumor promotion, this common cancer is initiated as hormone-responsive (HR), non-metastatic cancer, followed by a gradual transition into a

Zebrafish cnbp intron1 plays a fundament
✍ Andrea M.J. Weiner; Miguel L. Allende; Nora B. Calcaterra πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 553 KB

## Abstract Cellular nucleic acid binding protein (CNBP) is a strikingly conserved zinc‐finger nucleic acid chaperone required for forebrain development. Its depletion causes forebrain truncation mainly as a consequence of a reduction in size of craniofacial structures and neural crest derivatives.

PAR1 plays a role in epithelial malignan
✍ Rachel Bar-Shavit; Hagit Turm; Zaidoun Salah; Myriam Maoz; Irit Cohen; Einat Wei πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 887 KB

## Abstract Protease‐activated receptor1 (PAR~1~) is the first and prototype member of an established PAR family comprising four members. The role of PAR~1~ in tumor biology has been established, and is characterized by a consistent direct correlation between overexpression of its levels and epithe

Expression of major vault protein gene i
✍ Cristiane Arruda Dalla-Torre; Silvia Regina Caminada de Toledo; Maisa Yoshimoto; πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 120 KB

## Abstract Osteosarcoma (OS) is a primary malignant tumor of bone. Despite the successful use of multiple chemotherapeutic agents in the treatment of OS, more than 30% of OS tumors remain resistant to treatment. Elucidation of cellular resistance mechanisms may lead to better treatments for cancer